Gonzalo Calvo Selected Research

Gonzalo Calvo Research Topics

Disease

5	Myocardial Infarction 02/2024 - 11/2003
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 01/2021
3	Stroke (Strokes) 02/2024 - 01/2021
3	Anemia 01/2022 - 01/2021
3	Critical Illness (Critically Ill) 01/2016 - 06/2014
2	Heart Failure 02/2024 - 09/2013
2	Ischemia 02/2021 - 01/2021
2	Septic Shock (Toxic Shock Syndrome) 09/2015 - 06/2014
1	Drug Hypersensitivity (Drug Allergy) 07/2022
1	Immunoglobulin Light-chain Amyloidosis 12/2021
1	Multiple Myeloma 12/2021
1	Hematologic Neoplasms (Hematological Malignancy) 12/2021
1	Neoplasms (Cancer) 01/2021
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2021
1	Cytokine Release Syndrome 01/2021
1	Axial Spondyloarthritis 01/2019
1	Ankylosing Spondylitis 01/2019
1	Diabetes Mellitus 01/2016
1	Body Weight (Weight, Body) 01/2016
1	Multiple Organ Failure (MODS) 01/2016
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2014
1	Inflammation (Inflammations) 09/2013
1	Low Cardiac Output 09/2013
1	Thrombosis (Thrombus) 09/2013
1	Thrombophilia 09/2013
1	Thromboembolism 10/2012
1	Thrombocytopenia (Thrombopenia) 10/2012
1	Melanoma (Melanoma, Malignant) 01/2012
1	Experimental Melanoma 01/2012
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 09/2011
1	Liver Diseases (Liver Disease) 08/2006
1	Lipodystrophy 01/2005
1	Hypertension (High Blood Pressure) 01/2005
1	Albuminuria 11/2004
1	Disease Progression 04/2004

Drug/Important Bio-Agent (IBA)

3	omega-Chloroacetophenone (Mace)IBA 02/2024 - 01/2021
3	Chimeric Antigen ReceptorsIBA 12/2021 - 01/2021
2	VaccinesIBA 07/2022 - 01/2012
2	cyclic adenosine-5'-trimetaphosphate (ATMP)IBA 01/2022 - 10/2021
2	eltrombopag FDA Link 10/2012 - 09/2011
2	CholesterolIBA 01/2005 - 11/2003
2	Biomarkers (Surrogate Marker)IBA 11/2004 - 04/2004
1	BNT162 VaccineIBA 07/2022
1	2019-nCoV Vaccine mRNA-1273IBA 07/2022
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 12/2021
1	Amyloid (Amyloid Fibrils)IBA 12/2021
1	B-Cell Maturation AntigenIBA 12/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021
1	fludarabineIBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	Tumor Necrosis Factor InhibitorsIBA 01/2019
1	Infliximab (Remicade)FDA Link 01/2019
1	Adalimumab (Humira)FDA Link 01/2019
1	Etanercept (Enbrel)FDA Link 01/2019
1	golimumab FDA Link 01/2019
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 01/2016
1	Piperacillin FDA LinkGeneric 01/2016
1	Meropenem (Merrem)FDA LinkGeneric 09/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2014
1	beta-LactamsIBA 06/2014
1	Biosimilar PharmaceuticalsIBA 01/2014
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 09/2013
1	Protein CIBA 09/2013
1	Adenosine (Adenocard)FDA LinkGeneric 09/2013
1	Proteinase-Activated ReceptorsIBA 09/2013
1	Warfarin (Coumadin)FDA LinkGeneric 09/2013
1	Thrombopoietin ReceptorsIBA 10/2012
1	romiplostim FDA Link 10/2012
1	IpilimumabIBA 01/2012
1	Reverse Transcriptase InhibitorsIBA 01/2005
1	Antihypertensive Agents (Antihypertensives)IBA 01/2005
1	NucleosidesIBA 01/2005
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2005
1	Triglycerides (Triacylglycerol)IBA 11/2003

Therapy/Procedure

8	Therapeutics 01/2022 - 01/2012
3	Blood Transfusion (Blood Transfusions) 02/2024 - 01/2021
3	Continuous Renal Replacement Therapy 01/2016 - 06/2014
2	Highly Active Antiretroviral Therapy (HAART) 08/2006 - 11/2003
1	Erythrocyte Transfusion 02/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021
1	Drug Tapering 01/2019